Review Article | Open Access
Régida C. S. Batista, Caio V. B. Arruda, Marcely Cassimiro, Luciana Gominho, Antônio Carlos Moura, Diana S. Albuquerque, Kaline Romeiro, "The Role of the Dental Surgeon in Controlling the Dissemination of COVID-19: A Literature Review", The Scientific World Journal, vol. 2020, Article ID 7945309, 7 pages, 2020. https://doi.org/10.1155/2020/7945309
The Role of the Dental Surgeon in Controlling the Dissemination of COVID-19: A Literature Review
As early as December 2019 in the province of Hubei, China, contamination of patients with pneumonia of an unknown etiology occurred. These patients presented with symptoms such as coughing, sore throat, malaise, diarrhea, high fever, and dyspnea. This emerging disease was named COVID-19 due to being part of the group of coronaviruses (CoVs) belonging to the subfamily Orthocoronavirinae, in the Coronaviridae family and in the Nidovirales order. COVID-19 is most commonly transmitted through speech, coughing, sneezing, and salivary sputum. Because dental professionals work closely with the oral cavity, it is imperative that infection prevention controls are strictly adhered to. It is important that the dental profession treats patients while also limiting the possible contamination through the production of aerosol in the dental environment. Furthermore, the dental professional also has a key role in raising awareness and guidance amongst the population concerning COVID-19 related biosafety measures. This literature review aims to inform dental professionals about the COVID-19 pandemic and to present the implications of the virus to the dentist. Dental professionals are considered to be at high risk for contracting SARS-CoV-2.
The city of Wuhan, in Hubei province, is considered the most populous in China, with a population of over 11 million people. By December 31, 2019, 27 patients with pneumonia of an unknown etiology were identified [1–4]. These patients had clinical symptoms such as coughing, sore throat, malaise, diarrhea, persistent high fever, and dyspnea. Bilateral pulmonary changes were also found in medical imaging exams . Subsequently, the disease was identified as originating from the group of coronaviruses and was given the name COVID-19 by the World Health Organization (WHO) [1, 2]. Initially, several forms of human transmission were speculated to happen, such as oral, fecal, and vertical transmission (from mother to child) . However, its strongest form of transmission is through speech, coughing, sneezing, and salivary sputum .
The coronaviruses (COVs) belong to the subfamily Orthocoronavirinae, of the family Coronaviridae and of the order Nidovirales [4–6]. There are currently seven types and COVID-19 is the fourth being a variation of SARS-CoV, and its etiology is associated with bats [7, 8]. The first confirmed cases were associated with the wet live animal markets in the city of Wuhan, where fish and even snakes were being sold [9, 10]. Due to the severity of symptoms presented by those patients, they were hospitalized and underwent imaging and microbiological tests. Subsequently, the Chinese Center for Disease Control and Prevention (on January 10, 2020) publicly shared the gene sequence of the novel coronavirus and completed PCR diagnostic reagent development and testing [3, 10, 11]. To date, COVID-19 has now been detected in 213 countries and territories due to travel and transmission mainly through the expectoration of salivary fluids.
Transmission of COVID-19 via saliva droplets is significant because without precautionary measures, this transmission can occur when there is less than one meter of distance between two people . This directly affects the work of the dental professional as appointments with patients are typically lengthy and the distance between the professional and the patient is minimal . Furthermore, a substantial amount of dental procedures involve the production of aerosols. Therefore, it is believed that the dental professional is one of the most hazardous amongst medical professions when we consider the risk of COVID-19 related contamination . This literature review aims to inform the dental profession about the COVID-19 pandemic and its implications towards the profession of dentistry. In this context, the biosafety rules inherent to the profession are discussed and possible guidelines are presented for a more appropriate dental treatment.
2. Materials and Methods
To perform the literature review, the PubMed database was used. Indexed journals that had a correlation with the objective of the study were selected. The following were inclusion criteria for the literature search: COVID-19; SARS-CoV-2; SARS-CoV; Coronavirus; Spittle; Public health; Biosafety; Mouthwash; Infection; Disinfectant in combination with Dentistry. The exclusion criteria for the search included any articles not related to the topic.
The results obtained after the literature review can be seen in Table 1.
SARS-CoV-2 has a high potential for spreading through saliva, sneezing, coughing, and aerosols expelled through the respiratory tract , and it is considered a public health emergency. The knowledge about COVID-19 is limited. However, the disease seems to begin similarly to pneumonia but can then lead the patient to pulmonary fibrosis and even death [4, 25]. The SARS-CoV-2 RNA has a high mutation capacity due to its polymerase proliferative activity. The high mutation rate directly influences the evolutionary potential of the virus. Peng et al.  concluded that SARS-CoV-2 has a simple chain genome .
4.1. SARS-Cov-2 Transmission
Saliva can play a central role in the human-to-human transmission and the development of noninvasive salivary diagnosis can provide a platform for the rapid and early detection of SARS-CoV-2 infection in both a convenient and economical way . Recent reports state that the live virus was present in the saliva of infected individuals . It was also confirmed that the COVID-19 infection happens similarly to that of the SARS coronavirus through the ACE2 cell receptor . SARS-CoV-2 can effectively use the ACE2 as a receptor to invade cells, which can promote human-to-human transmission. ACE2 positive cells have been found abundantly present throughout the respiratory tract and cells morphologically compatible with the salivary gland in the human mouth.
The expression of ACE2 in minor salivary glands was higher than in the lungs which suggest that salivary glands could be potentially targeted by COVID-19 . Saliva samples could be collected from patients who present oropharyngeal secretion as one of the symptoms . Furthermore, it provides the opportunity to determine a diagnosis through a noninvasive saliva sample. This could increase the detection of COVID-19 and reduce the spread of the virus. Initially, the most frequently performed laboratory diagnostic tests are involved with nasopharyngeal, oropharyngeal, and blood samples. Sputum and other samples in severe respiratory illnesses were also considered as samples of the lower respiratory tract [29, 30].
4.2. Understanding COVID-19 Spread Cycle in the Dental Clinic
More research is needed regarding the detection of coronavirus in oral fluids and its impact on the transmission of the virus. This will be crucial in improving infection prevention strategies, especially for dentists and other health professionals who perform aerosols-producing procedures. The outbreak of COVID-19 requires the dental professional to take precautions and follow the biosafety measures that prevent the spread of the virus .
The transmission of SARS-CoV-2 is the most important concern in dental clinics and hospitals because it is difficult to avoid the generation of large amounts of aerosols, droplets, and even blood mixed with the patient’s saliva during clinical practice . Aerosols are solid or liquid particles containing bacteria or viruses, suspended (for at least a few seconds) in a gas . The smaller particles of aerosol (0.5 to 10 μmm in diameter) have the potential to penetrate and lodge in the smaller passages of the lungs and are thought to possess the greatest potential for transmitting SARS-CoV-2 . Therefore, according to Sabino-Silva et al. , there is a high risk of transmitting the COVID-19 disease while performing dental procedures because when the operator is working with dental equipment in the oral cavity, such as with high-speed handpieces, there is a significant amount of aerosols generation. Particles, droplets, and aerosols are small enough to remain in the air for a long period before settling on environmental surfaces or entering the respiratory tract.
Potential contamination routes can be bidirectional, meaning the transmission may occur from patient-to-patient, dentist-to-patient, and patient-to-dentist  and also between dentists. Thus, the dentist could be an important vector during the pandemic and could promote cross infection. Therefore, the use of personal protective equipment (PPE), such as masks, glasses, visors, chemical and physical protection barriers, constant disinfection of utensils with 70% alcohol, attention to aerosols produced and disseminated by the use of equipment such as high and low speed pens, and ultrasound equipment must be considered. Sattar et al.  specified that chemical agents commonly utilized for surface disinfection are tested against SARS-CoV-2 to ensure efficacy.
In this context, health care workers, such as dentists, maybe unaware of how to provide care to patients with asymptomatic infection . Asymptomatic infections seem to be possible , and transmission can occur before symptoms of the disease appear. A recent clinical study indicates that 29% of 138 patients hospitalized due to COVID-19 infection in Wuhan (China) were healthcare professionals . As in bronchoscopy, the inhalation of airborne aerosol particles produced during dental procedures in patients with COVID-19 could cause a high risk for COVID-19 exposure to the dental professional. Therefore, it is crucial for dentists to refine preventive strategies to prevent COVID-19 infection, focusing on patient placement, hand hygiene, using PPE, and exercising caution when performing aerosol-generating procedures .
4.3. Dental Infection Control Practice
According to Qu and Zhou , Ji et al. , and Guan et al. , dental surgeons need to have the knowledge necessary to identify suspected COVID-19 cases. During examination, patients should be asked if they have experienced influenza in the last 14 days, if they have travelled to a highly contaminated area, if they have a fever or were in contact with someone presenting COVID-19 symptoms, in order to interrupt the virus’ spread cycle. They should also guide patients and exercise empathy, as the most emotionally fragile patients may develop some oral changes due to the stress caused by the dissemination of false information, which can cause emotional imbalance. These patients may have oral psychosomatic disorders such as dry mouth, burning mouth, atypical toothache, halitosis, bruxism, oral paresthesia, and recurrent aphthous ulcers. These symptoms usually occur due to changes in physical and emotional conditions. In addition, severe SARS-CoV-2 infection along with associated therapy has the potential to contribute to poor oral health such as various opportunistic fungal infections, dry mouth linked to decreased salivary flow, ulcerations, and gingivitis as a result of the compromised immune system and/or susceptible oral environment .
According to Sohrabi et al. , Peng et al. , and Wang et al. , dental professionals also have the responsibility of guiding the population on preventive measures to minimize the risks of spreading COVID-19. Simple guidelines should be taught, such as washing hands constantly with soap and water, using 70% alcohol, using alcohol gel, covering your mouth and nose when coughing and sneezing with absorbent paper, being careful in the use and storage of toothbrushes, and maintaining good oral hygiene to control microorganisms.
The pandemic caused by SARS-Cov-2 directly impacts the type of contact between dental professionals and patients [22–24, 26, 32, 33, 37]. This situation has forced dental professionals to postpone nonurgent consultations as a means of safety and perform emergency treatment only. In studies carried out in Germany, contamination of professionals even when the patient had no symptoms was found [3, 4]. Thus, dental care during the pandemic requires even more expressive care with biosafety measures.
At the dental clinic, the whole environment should be considered high risk. Therefore, it is recommended that the dental office provide mask and disinfectant alcohol and that magazines, ornaments, and objects that may spread the virus contagion be removed [17, 38]. Once in the office, the temperature of the patient should be measured with a digital thermometer on the forehead to identify possible fever. If the patient is in an acute febrile state, the appointment should be rescheduled, and the patient should be advised to see a physician .
The professional must use PPE appropriately, such as a mask to restrict the spread of fluids, goggles, or face protection and gloves, to avoid cross contamination. Chemical and physical barriers must be properly used, and no appointments should be scheduled for nonurgent procedures, especially in patients with the flu or similar symptoms. Also, biological waste and contaminating materials must be properly disposed of [22, 39].
Before and after the procedures, the professional must be very careful with the risks inherent to cross contamination, since the use of masks does not effectively protect from particles below 05 nm. It is well established that surgical masks do not provide sufficient protection against airborne transmission. The European Standard [EN 149:2001] classifies respirator masks into three different categories: filtering facepiece FFP1, FFP2, and FFP3. The FFP2 is comparable to the US standard N95 . In cases of proven or suspected COVID-19 infection, the safest options are the N95, FFP2 and FFP3 masks because they are more suitable for protection against biological agents. FFP2 and FFP3 have minimum filtration efficiencies of 94% and 99%, respectively . The use of a FFP2/FFP3 (face filtering piece) respirator mask is recommended for all aerosol-generating procedures performed when caring for patients .
The use of gowns is also indicated during dental practice. In the USA, ANSI/AAMI PB70 2012 standard classifies surgical and isolation gowns according to their liquid barrier performance with four levels of protection with level 4 offering the most protection against viral and liquid penetration . Level 4 gowns are preserved for high-risk procedures such as surgery or when infectious diseases are suspected according to the American Society for Testing Materials . Thus, for clinical dental care during the COVID-19 pandemic, level 4 gowns are the best choice and should be used. Additionally, nonsterile, disposable patient isolation gowns, which are used for routine patient care in healthcare settings, are also appropriate for use by healthcare personnel when caring for patients with suspected or confirmed COVID-19. In times of gown shortages, surgical gowns should be prioritized for surgical and other sterile procedures .
It is noteworthy that the process of removing PPE has the highest risk of contact transfer of viruses from the PPE surface to the skin of healthcare workers [46, 47]. Therefore, it is important to know that the contamination critical zone of a surgical gown comprises the front area of the gown from the chest to the knees and the sleeves from the cuff to above the elbow. The dental professional should be careful not to touch their eyes, nose, and mouth, without proper hand disinfection.
According to Peng et al. , the virus is very sensitive to heat and ultraviolet light and can be combated with disinfectant hygiene products, water and soap. According to Kampf , Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle Eastern Respiratory Syndrome coronavirus (MERS), or SARS-CoV-2 endemic human coronavirus can persist on inanimate surfaces such as metal, glass, or plastic for up to 9 days but can be effectively inactivated by performing surface disinfection procedures with 62–71% ethanol, 0.5% hydrogen peroxide, or 0.1% sodium hypochlorite for 1 minute .
It is also known that the SARS-CoV-2 is not effectively inactivated with chlorhexidine. However, agents such as 1% hydrogen peroxide or 0.2% povidone are recommended to reduce the viral load in the oral environment as they are more effective. Tested povidone-iodine products have strong virucidal activities against SARS-CoV , so they have great potential for SARS-CoV-2. However, the combination of chlorhexidine and cetrimide, widely used in human medicine, does not appear to be effective in SARS-COVs, unless ethanol is added. Other mouthwash and/or nasal applications proposed to combat COVID-19 are those that are derived from cyclodextrins combined with Citrox. Together, these compounds could decrease the SARS-CoV-2 viral load and reduce the nasopharyngeal microbiota, which tends to coat the surface of aerosol particles and droplets during coughing or sneezing . This information highlights the need to evaluate the activities of antiseptics and disinfectants against the coronavirus, to ensure its efficiency and develop targeted antisepsis. In addition, the use of intraoral imaging tests should be avoided or performed with great care, as the intraoral radiography device stimulates salivation and pharyngeal reflexes which can induce vomiting. It is indicated to give preference to extraoral radiographic exams or CT scans [3, 29].
According to Meng et al. , for a patient who will need urgent treatment, such as a patient with a diagnosis of symptomatic irreversible pulpitis, or painful symptoms due to trauma, the procedure should be performed using absolute isolation and high-volume evacuation. If there is a need for surgery to be performed, preference should be given to absorbable suture threads for soft tissues. If the patient is considered suspected for COVID-19, the dentist should make use of all routine biosafety measures without neglecting any step and make the appointment for this patient either at the end of the work day or provide care in an isolated room to avoid the cross contamination in the office .
Overall, any dental procedure that has the potential to generate salivary aerosol could cause airborne contamination of COVID-19. Air purification techniques are needed inside the dental office. As an example, there are HEPA (high-efficiency air) systems, which direct air through a series of prefilters, which help to continuously catch airborne microorganisms and retain particles as small as 0.3 μm to assist in purifying the air in and outside of dental operatories  ensuring an environment free of potentially dangerous microorganisms. In the near future, the concept of an ultraclean care room should also be used more in dental offices. In view of the inherent conditions of air contamination by aerosols generated in the dental office, the use of equipment with devices that emit ultraviolet rays, hydrogen peroxide systems, filters, and internal air renewal may soon be a reality in dentistry [52, 53].
COVID-19 does not have a defined treatment. Dentistry professionals are considered to be at high risk for contracting COVID-19. This is strongly due to COVID-19 transmission through saliva. In light of the high risk of contamination during dental care, only emergency treatment should be performed and PPE such as N95 /FFP2 or FFP3 masks, disposable cloaks, visors, goggles, disposable caps, and gloves should be used. Guidance should be given to patients on maintaining good oral hygiene during the pandemic.
No data were used in the study.
Conflicts of Interest
The authors have declared that there are no conflicts of interest in relation to the publication of this article.
- Y. Chen, Y. Guo, Y. Pan, and Z. J. Zhao, “Structure analysis of the receptor binding of 2019-nCoV,” Biochemical and Biophysical Research Communications, vol. 525, no. 1, pp. 135–140, 2020.
- L. Meng, F. Hua, and Z. Bian, “Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine,” Journal of Dental Research, vol. 99, no. 5, pp. 481–487, 2020.
- X. Pan, D. M. Ojcius, T. Gao, Z. Li, C. Pan, and C. Pan, “Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases,” Microbes and Infection, vol. 22, no. 2, pp. 86–91, 2020.
- X. Peng, X. Xu, Y. Li, L. Cheng, X. Zhou, and B. Ren, “Transmission routes of 2019-nCoV and controls in dental practice,” International Journal of Oral Science, vol. 12, no. 1, pp. 1–6, 2020.
- C. Sohrabi, Z. Alsafi, N. O’Neill et al., “World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19),” International Journal of Surgery, vol. 76, pp. 71–76, 2020.
- W. Iosifidis, R.-H. Du, B. Li et al., “Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes,” Emerging Microbes & Infections, vol. 9, no. 1, pp. 386–389, 2020.
- C. I. Paules, H. D. Marston, and A. S. Fauci, “Coronavirus infections-more than just the common cold,” JAMA, vol. 323, no. 8, pp. 707-708, 2020.
- W. Ji, W. Wang, X. Zhao, J. Zai, and X. Li, “Cross-species transmission of the newly identified coronavirus 2019-nCoV,” Journal of Medical Virology, vol. 92, no. 4, pp. 433–440, 2020.
- Z. Shen, Y. Xiao, L. Kang et al., “Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019,” Clinical Infectious Diseases, vol. 71, no. 15, pp. 713–720, 2019.
- M. L. Holshue, C. DeBolt, S. Lindquist et al., “First case of 2019 novel coronavirus in the United States,” New England Journal of Medicine, vol. 382, no. 10, pp. 929–936, 2020.
- W.-J. GuanZ.-Y. NiY. Hu et al., “Clinical characteristics of coronavirus disease 2019 in China,” New England Journal of Medicine, vol. 382, no. 18, pp. 1708–1720, 2020.
- X. Qu and X. D. Zhou, “Psychological intervention in oral patients in novel coronavirus pneumonia outbreak period,” Chinese Journal of Stomatology, vol. 55, no. 4, pp. 235–240, 2020.
- R. Sabino-Silva, A. C. G. Jardim, and W. L. Siqueira, “Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis,” Clinical Oral Investigations, vol. 24, no. 4, pp. 1619–1621, 2020.
- H. Kariwa, N. Fujii, and I. Takashima, “Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents,” Dermatology, vol. 212, no. 1, pp. 119–123, 2006.
- A. Segal and D. T. Wong, “Salivary diagnostics: enhancing disease detection and making medicine better,” European Journal of Dental Education, vol. 12, no. 1, pp. 22–29, 2008.
- J. L. Cleveland, S. K. Gray, J. A. Harte, V. A. Robison, A. C. Moorman, and B. F. Gooch, “Transmission of blood-borne pathogens in US dental health care settings: 2016 update,” The Journal of the American Dental Association, vol. 147, no. 9, pp. 729–738, 2016.
- A. Ather, B. Patel, N. B. Ruparel, A. Diogenes, and K. M. Hargreaves, “Coronavirus disease 19 (COVID-19): implications for clinical dental care,” Journal of Endodontics, vol. 46, no. 5, pp. 584–595, 2020.
- F. Carrouel, M. P. Conte, J. Fisher et al., “COVID-19: a recommendation to examine the effect of mouthrinses with β-cyclodextrin combined with citrox in preventing infection and progression,” Journal of Clinical Medicine, vol. 9, no. 4, p. 1126, 2020.
- P. S. Casamassimo, J. A. Townsend, and C. S. Litch, “Pediatric dentistry during and after COVID-19,” Pediatric Dentistry, vol. 42, no. 2, pp. 87–90, 2020.
- P. Coulthard, “Dentistry and coronavirus (COVID-19)—moral decision-making,” British Dental Journal, vol. 228, no. 7, pp. 503–505, 2020.
- A. Dziedzic and R. Wojtyczka, “The impact of coronavirus infectious disease 19 (COVID-19) on oral health,” Oral Diseases, pp. 1–4, 2020.
- Z. Y. Li and L. Y. Meng, “The prevention and control of a new coronavirus infection in department of stomatology,” Chinese Journal of Stomatology, vol. 55, Article ID E001, 2020.
- C. Prati, G. A. Pelliccioni, V. Sambri, S. Chersoni, and M. G. Gandolfi, “COVID-19: its impact on dental schools in Italy, clinical problems in endodontic therapy and general considerations,” International Endodontic Journal, vol. 53, no. 5, pp. 723–725, 2020.
- K. K. W. To, O. T. Y. Tsang, C. Chik-Yan Yip et al., “Consistent detection of 2019 novel coronavirus in saliva,” Clinical Infectious Diseases, vol. 71, no. 15, pp. 841–843, 2020.
- H. Xu, L. Zhong, J. Deng et al., “High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa,” International Journal of Oral Science, vol. 12, no. 1, p. 8, 2020.
- Z. Wu and J. M. McGoogan, “Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention,” JAMA, vol. 323, no. 13, pp. 1239–1242, 2020.
- S. A. Sattar, V. S. Springthorpe, Y. Karim, and P. Loro, “Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses,” Epidemiology and Infection, vol. 102, no. 3, pp. 493–505, 1989.
- J. Xu, Y. Li, F. Gan, Y. Du, and Y. Yao, “Salivary glands: potential reservoirs for COVID-19 asymptomatic infection,” Journal of Dental Research, vol. 99, no. 8, p. 989, 2020.
- C. Wang, P. W. Horby, F. G. Hayden, and G. F. Gao, “A novel coronavirus outbreak of global health concern,” The Lancet, vol. 395, no. 10223, pp. 470–473, 2020.
- N. Zhu, D. Zhang, W. Wang et al., “A novel coronavirus from patients with pneumonia in China, 2019,” New England Journal of Medicine, vol. 382, no. 8, pp. 727–733, 2020.
- G. Gupta, D. Mitra, K. P. Ashok et al., “Efficacy of preprocedural mouth rinsing in reducing aerosol contamination produced by ultrasonic scaler: a pilot study,” Journal of Periodontology, vol. 85, no. 4, pp. 562–568, 2014.
- S. Acharya, H. Priya, B. Purohit, and M. Bhat, “Aerosol contamination in a rural university dental clinic in south India,” International Journal of Infection Control, vol. 6, no. 1, pp. 1–7, 2010.
- A. M. G. A. Laheij, J. O. Kistler, G. N. Belibasakis, H. Valimaa, and J. J. de Soet, “Healthcare-associated viral and bacterial infections in dentistry,” Journal of Oral Microbiology, vol. 4, no. 1, Article ID 17659, 2012.
- J. F.-W. Chan, S. Yuan, K.-H. Kok et al., “A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster,” The Lancet, vol. 395, no. 10223, pp. 514–523, 2020.
- M. Wang, R. Cao, L. Zhang et al., “Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro,” Cell Research, vol. 30, no. 3, pp. 269–271, 2020.
- Group of Interventional Respiratory Medicine and CTS, “Expert consensus for bronchoscopy during the epidemic of 2019 novel coronavirus infection (trial version),” Chinese Journal of Tuberculosis and Respiratory Diseases, vol. 43, no. 3, pp. 199–202, 2020.
- F. Zhou, T. Yu, R. Du et al., “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study,” The Lancet, vol. 395, no. 10229, pp. 1054–1062, 2020.
- G. Spagnuolo, D. De Vito, S. Rengo, and M. Tatullo, “COVID-19 outbreak: an overview on dentistry,” International Journal of Environmental Research and Public Health, vol. 17, no. 6, Article ID 2094, 2020.
- M. Malta, A. W. Rimoin, and S. A. Strathdee, “The coronavirus 2019-nCoV epidemic: is hindsight 20/20?” EClinicalMedicine, vol. 20, Article ID 1, 2020.
- S. A. Lee, D. C. Hwang, H. Y. Li, C. F. Tsai, C. W. Chen, and J. K. Chen, “Particle size-selective assessment of protection of European standard FFP respirators and surgical masks against particles-tested with human subjects,” Journal of Healthcare Engineering, vol. 2016, Article ID 8572493, 12 pages, 2016.
- F. A. Villani, R. Aiuto, L. Paglia, and D. Re, “COVID-19 and dentistry: prevention in dental practice, a literature review,” nternational Journal of Environmental Research and Public Health, vol. 17, no. 12, pp. 1–12, 2020.
- B. Bein, M. Bachmann, S. Huggett, and P. Wegermann, “SARS-CoV-2/COVID-19: evidence-based recommendation on diagnosis and therapy,” AINS—Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie, vol. 55, no. 4, pp. 257–265, 2020.
- J. H Verbeek, B. Rajamaki, S. Ijaz et al., “Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff,” Cochrane Database of Systematic Reviews, vol. 7, no. 7, Article ID CD011621, pp. 1–147, 2020.
- American Society for Testing and Materials (ASTM), 2020, http://www.astm.org/COVID-19/.
- Centers for Disease Control and Prevention, Strategies for Optimizing the Supply of Isolation Gowns, Centers for Disease Control and Prevention, Atlanta, GA, USA, 2019, https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/isolation-gowns.html.
- A. L. Hewlett, J. B. Varkey, P. W. Smith, and B. S. Ribner, “Ebola virus disease: preparedness and infection control lessons learned from two biocontainment units,” Current Opinion in Infectious Diseases, vol. 28, no. 4, pp. 343–348, 2015.
- W. A. Fischer and D. A. Wohl, “Confronting ebola as a sexually transmitted infection,” Clinical Infectious Diseases, vol. 62, no. 10, pp. 1272–1276, 2016.
- G. Kampf, Antiseptic Stewardship: Biocide Resistance and Clinical Implications, Springer International Publishing, Berlin, Germany, 2018.
- National Health Commission, Guidelines for the Prevention, Diagnosis, and Treatment of Novel Coronavirus-Induced Pneumonia, National Health Commission, Beijing, China, 6th edition, 2020.
- European Centre for Disease Prevention and Control, European Surveillance for Human Infection with Novel Coronavirus (COVID-19), European Centre for Disease Prevention and Control, Solna Municipality, Sweden, 2020, https://www.ecdc.europa.eu/en/european-surveillance-humaninfection-novel-coronavirus-COVID-19.
- C. Hallier, D. W. Williams, A. J. C. Potts, and M. A. O. Lewis, “A pilot study of bioaerosol reduction using an air cleaning system during dental procedures,” British Dental Journal, vol. 209, no. 8, pp. 9–11, 2010.
- J. Wong, Q. Y. Goh, Z. Tan et al., “Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore,” Canadian Journal of Anesthesia, vol. 67, no. 6, pp. 732–745, 2020.
- D. J. Weber, H. Kanamori, and W. A. Rutala, ““No touch” technologies for environmental decontamination,” Current Opinion in Infectious Diseases, vol. 29, no. 4, pp. 424–431, 2016.
Copyright © 2020 Régida C. S. Batista et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.